UBS Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $546M | Buy |
5,177,796
+2,407,775
| +87% | +$213M | 0.1% | 250 |
|
|
2025
Q4 | $242M | Buy |
2,770,021
+874,013
| +46% | +$71.5M | 0.05% | 487 |
|
|
2025
Q3 | $126M | Sell |
1,896,008
-605,243
| -24% | -$34.4M | 0.02% | 872 |
|
|
2025
Q2 | $138M | Buy |
2,501,251
+2,148,380
| +609% | +$103M | 0.03% | 747 |
|
|
2025
Q1 | $17.1M | Buy |
352,871
+220,262
| +166% | +$9.23M | ﹤0.01% | 2508 |
|
|
2024
Q4 | $5.12M | Buy |
132,609
+53,810
| +68% | +$2.35M | ﹤0.01% | 3823 |
|
|
2024
Q3 | $3.55M | Buy |
78,799
+11,818
| +18% | +$477K | ﹤0.01% | 3418 |
|
|
2024
Q2 | $2.32M | Sell |
66,981
-110,565
| -62% | -$3.24M | ﹤0.01% | 3610 |
|
|
2024
Q1 | $5.14M | Buy |
177,546
+26,679
| +18% | +$726K | ﹤0.01% | 2944 |
|
|
2023
Q4 | $3.46M | Buy |
150,867
+60,141
| +66% | +$1.05M | ﹤0.01% | 3176 |
|
|
2023
Q3 | $1.51M | Buy |
90,726
+25,186
| +38% | +$489K | ﹤0.01% | 3715 |
|
|
2023
Q2 | $1.81M | Sell |
65,540
-50,399
| -43% | -$1.26M | ﹤0.01% | 3630 |
|
|
2023
Q1 | $2.67M | Sell |
115,939
-109,590
| -49% | -$1.84M | ﹤0.01% | 3122 |
|
|
2022
Q4 | $2.46M | Buy |
225,529
+178,949
| +384% | +$1.51M | ﹤0.01% | 3189 |
|
|
2022
Q3 | $393K | Sell |
46,580
-82,407
| -64% | -$780K | ﹤0.01% | 4550 |
|
|
2022
Q2 | $1.02M | Buy |
128,987
+6,222
| +5% | +$75.2K | ﹤0.01% | 3732 |
|
|
2022
Q1 | $2.91M | Buy |
122,765
+56,454
| +85% | +$1.59M | ﹤0.01% | 3079 |
|
|
2021
Q4 | $2.27M | Sell |
66,311
-2,904
| -4% | -$91.8K | ﹤0.01% | 3615 |
|
|
2021
Q3 | $1.23M | Buy |
69,215
+66,544
| +2,491% | +$2.84M | ﹤0.01% | 4009 |
|
|
2021
Q2 | $120K | Sell |
2,671
-41,902
| -94% | -$1.38M | ﹤0.01% | 5746 |
|
|
2021
Q1 | $1.15M | Sell |
44,573
-20,360
| -31% | -$515K | ﹤0.01% | 4106 |
|
|
2020
Q4 | $1.31M | Buy |
64,933
+10,445
| +19% | +$225K | ﹤0.01% | 3789 |
|
|
2020
Q3 | $1.06M | Sell |
54,488
-14,199
| -21% | -$266K | ﹤0.01% | 3591 |
|
|
2020
Q2 | $1.21M | Sell |
68,687
-4,546
| -6% | -$57K | ﹤0.01% | 3340 |
|
|
2020
Q1 | $517K | Buy |
73,233
+52,074
| +246% | +$390K | ﹤0.01% | 3932 |
|
|
2019
Q4 | $149K | Buy |
21,159
+4,540
| +27% | +$45.1K | ﹤0.01% | 5786 |
|
|
2019
Q3 | $200K | Sell |
16,619
-87,582
| -84% | -$1.1M | ﹤0.01% | 5255 |
|
|
2019
Q2 | $1.26M | Buy |
104,201
+102,556
| +6,234% | +$1.13M | ﹤0.01% | 3555 |
|
|
2019
Q1 | $21K | Sell |
1,645
-218
| -12% | -$1.92K | ﹤0.01% | 6277 |
|
|
2018
Q4 | $12K | Sell |
1,863
-5,192
| -74% | -$41.2K | ﹤0.01% | 7145 |
|
|
2018
Q3 | $73K | Sell |
7,055
-33,946
| -83% | -$292K | ﹤0.01% | 5847 |
|
|
2018
Q2 | $276K | Buy |
+41,001
| New | +$315K | ﹤0.01% | 4738 |
|
|
2018
Q1 | – | Sell |
-388
| Closed | -$8K | – | 8089 |
|
|
2017
Q4 | $8K | Buy |
388
+79
| +26% | +$1.4K | ﹤0.01% | 7166 |
|
|
2017
Q3 | $5K | Sell |
309
-1,362
| -82% | -$18.9K | ﹤0.01% | 7228 |
|
|
2017
Q2 | $19K | Buy |
1,671
+1,342
| +408% | +$14.3K | ﹤0.01% | 6342 |
|
|
2017
Q1 | $4K | Sell |
329
-1,114
| -77% | -$18K | ﹤0.01% | 7082 |
|
|
2016
Q4 | $32K | Buy |
1,443
+374
| +35% | +$8.34K | ﹤0.01% | 6183 |
|
|
2016
Q3 | $23K | Buy |
+1,069
| New | +$14.6K | ﹤0.01% | 6193 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ
